Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Linker Chemistry in Radiopharmaceutical Design.

Bioconjugate chemistry·2026
Same author

Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Pharmacokinetic Optimization of Radiocopper-Based Theranostic Pretargeting.

Molecular pharmaceutics·2026
Same author

Harnessing Frémy's salt for tyrosine-directed bioconjugations.

RSC advances·2026
Same author

Harnessing Fc-Directed Bioconjugation for the Synthesis of Site-Specifically Modified Radioimmunoconjugates.

Bioconjugate chemistry·2025
Same author

Exploring Auger electron-emitting radionuclides for targeted DNA damage in mismatch repair-deficient cells: a theoretical study of <sup>99</sup>Rh- and <sup>123</sup>I-labeled metalloinsertors.

International journal of radiation biology·2025

相关实验视频

Updated: Sep 10, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.8K

评估子宫内膜癌的放射性点

Joni Sebastiano1,2,3, Shane A McGlone1, Zachary V Samuels1,2,4

  • 1Department of Chemistry, Hunter College, City University of New York, New York, New York.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
|August 21, 2025
PubMed
概括

针对人体表皮生长因子受体2 (HER2) 和CD24的新型免疫PET探针显示出对子宫内膜癌的成像潜力. 这些药物可能有助于对疾病进行非侵入性分期和监测.

关键词:
CD24 其他在HER2其他国家在PET子宫内膜癌放射性药物

更多相关视频

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K

相关实验视频

Last Updated: Sep 10, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.8K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K

科学领域:

  • 癌症学
  • 放射化学
  • 分子成像

背景情况:

  • 子宫内膜癌是一种常见的妇科恶性瘤,发病率和死亡率都在增加.
  • 对于晚期或复发的子宫内膜癌,存在有限的向治疗方法,需要改进诊断工具.
  • 人类表皮生长因子受体2 (HER2),素-16 (MUC16) 和CD24等生物标志物被视为潜在的标.

研究的目的:

  • 研究HER2,MUC16和CD24作为子宫内膜癌的潜在放射性点.
  • 开发和评估用于检测子宫内膜癌的新型免疫子发射断层扫描 (免疫PET) 探针.

主要方法:

  • 在癌症和健康细胞/组织中评估免疫细胞化学和免疫光染色体表达.
  • 针对HER2,MUC16和CD24的单克隆抗体与deferoxamine (DFO) 结合,并用Zirconium-89 ([89Zr]) 进行放射性标记.
  • 在卵巢癌小鼠模型中进行了体内PET成像和生物分布研究.

主要成果:

  • 与对照组相比,子宫内膜癌细胞和组织表达HER2,MUC16和CD24的增加.
  • 开发的免疫PET探针 ([89Zr]Zr-DFO-trastuzumab,[89Zr]Zr-DFO-AR9.6,[89Zr]Zr-DFO-ATG-031) 已成功合成,具有高纯度和特定活性.
  • 在临床前模型中,针对CD24的探针 ([89Zr]Zr-DFO-ATG-031) 和针对HER2的探针 ([89Zr]Zr-DFO-trastuzumab) 显示出显著的瘤吸收和对比度.

结论:

  • 针对CD24和HER2的免疫PET探针显示出对子宫内膜癌的非侵入性成像的显著潜力.
  • 这些探测器可以促进疾病的分期,监测,并作为针对性治疗的辅助剂.
  • 需要进一步的临床评估来证实这些放射性剂的有用性.